Review article: In vitro studies of gall-bladder smooth muscle function. Relevance in cholesterol gallstone disease

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 14, Issue 2, 2000, Pages 19-26

  Portincasa, P ^b,c   Minerva, F ^b   Moschetta, A ^b   Venneman, N ^a,b   Vanberge Henegouwen, G P ^a,b   Palasciano, G ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; DEOXYCHOLIC ACID; MEMBRANE RECEPTOR;

CHOLESTEROL STONE; CONFERENCE PAPER; DIET RESTRICTION; GALLBLADDER EMPTYING; GALLBLADDER FUNCTION; GALLBLADDER MOTILITY; HISTOLOGY; HUMAN; MUSCLE TONE; MYOPATHY; NONHUMAN; PATHOGENESIS; PHASE CONTRAST MICROSCOPY; POSTPRANDIAL STATE; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SMOOTH MUSCLE; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION;

EID: 0034038449     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2000.014s2019.x     Document Type: Conference Paper

References (84)

1. Carey MC. Formation of cholesterol gallstones: the new paradigm. In: Paumgartner G, Stiehl A, Gerok W, eds. Trends in Bile Acid Research. Dordrecht: Kluwer Academic Publishers: 1989; 259-81.
2. Apstein MD, Carey MC. Pathogenesis of cholesterol gallstones: a parsimonious hypothesis. Eur J Clin Invest 1996; 26: 343-52.
3. Konikoff FM, Chung DS, Donovan JM, Small DM, Carey MC. Filamentous, helical and tubular microstructures during cholesterol crystallization from bile. Evidence that biliary cholesterol does not nucleate classic monohydrate plates. J Clin Invest 1992; 90: 1156-61.
4. Portincasa P, van Erpecum KJ, Jansen A, Renooij W, Gadellaa M, vanBerge-Henegouwen GP. Behavior of various cholesterol crystals in bile from gallstone patients. Hepatology 1996; 23: 738-48.
5. Portincasa P, van Erpecum KJ, vanBerge-Henegouwen GP. Cholesterol crystallisation in bile. Gut 1997; 41: 138-41.
6. Carey MC. Formation and growth of cholesterol gallstones: the new synthesis. In: Fromm H, Leushner U, eds. Bile Acids -Cholestasis - Gallstones. Advances in Basic and Clinical Bile Acid Research. Dordrecht: Kluwer Academic Publishers: 1996; 147-75.
7. Portincasa P. Gallbladder and bile in health and gallstone disease. The role of motility, gallstones and bile lipid composition. PhD Thesis. Utrecht: Utrecht University, 1995.
8. Portincasa P, Stolk MF, van Erpecum KJ, Palasciano G, vanBerge-Henegouwen GP. Cholesterol gallstone formation in man and potential treatments of the gallbladder motility defect. Scand J Gastroenterol 1995; 212 (Suppl): 63-78.
9. LaMorte WW. Biliary motility and abnormalities associated with cholesterol cholelithiasis. Curr Opin Gastroenterol 1993; 9: 810-6.
10. Weisbrodt NW. Regulation: nerves and smooth muscle. In: Johnson LR, ed. Gastrointestinal Physiology, 5th edn. St Louis, MI: Mosby-Year Book Inc: 1997; 325-32.
11. Ruegg JC. Smooth muscle. In: Greger R, Windhorst U, eds. Comprehensive Human Physiology. Berlin Heidelberg: Springer-Verlag: 1996; 895-910.
12. Ruegg JC. Calcium in muscle contraction, 2nd edn. Berlin, Heidelberg New York: Springer, 1992.
13. Small JV, Squire JM. Structural basis of contraction in vertebrate smooth muscle. J Mol Biol 1972; 67: 117-9.
14. Weisbrodt NW, Moody FG. Gallbladder contractility. Gastroenterology 1992; 102: 741-2 (letter).
15. Shaw MJ, Hadac EM, Miller LJ. Preparation of enriched plasma membranes from bovine gallbladder muscularis for characterization of cholecystokinin receptors. J Biol Chem 1987; 262: 14313-8.
16. Schjoldager B, Shaw MJ, Powers SP, Schmalz PF, Szurszewski J, Miller LJ. Bovine gallbladder muscularis: source of a myogenic receptor for cholecystokinin. Am J Physiol 1988; 254: G294-G299.
17. Poston GJ, Singh P, Maclellan DG, et al. Age-related changes in gallbladder contractility and gallbladder cholecystokinin receptor population in the guinea pig. Mech Ageing Dev 1988; 46: 225-36.
18. Gomez G, Townsend CM Jr, Maani R, Singh P, Greeley GG Jr, Thompson JC. Down-regulation of pancreatic growth and gallbladder contractility by bile salts. Am J Surg 1989; 157: 20-6.
19. Poston GJ, Singh P, Draviam E, Yao CZ, Gomez G, Thompson JC. Early stages of gallstone formation in guinea pig are associated with decreased biliary sensitivity to cholecystokinin. Dig Dis Sci 1992; 37: 1236-44.
20. Schjoldager BT. Role of CCK in gallbladder function. Ann NY Acad Sci 1994; 713: 207-18.
21. Portincasa P, Howard A, Murphy GM, Dowling RH. Cholecystokinin receptor binding by human gallbladder myocyte membranes. Gut 1986; 27: 1261A (abstract).
22. Portincasa P, Murphy GM, Dowling RH, et al. A method proposed for the preparation of plasma membranes from myocytes of human gallbladders. In: Gorrod JW, Albano O, Papa S, eds. Molecular Aspect of Human Disease. London: Ellis Horwood: 1988; 241-9.
23. Schjoldager B, Molero X, Miller LJ. Functional and biochemical characterization of the human gallbladder muscularis cholecystokinin receptor. Gastroenterology 1989; 96: 1119-25.
24. Upp JR Jr, Nealon WH, Singh P, et al. Correlation of cholecystokinin receptors with gallbladder contractility in patients with gallstones. Ann Surg 1987; 205: 641-8.
25. Xiao ZL, Chen Q, Amaral J, Biancani P, Jensen RT, Behar J. CCK receptor dysfunction in muscle membranes from human gallbladders with cholesterol stones. Am. J Physiol 1999; 276: G 1401-7.
26. Schjoldager B, Molero X, Miller LJ. Gallbladder CCK receptors: species differences in glycosylation of similar protein cores. Regul Peptides 1990; 28: 265-72.
27. Oliver AS, Vigna SR. CCK-A and CCK-B-like receptors in the gallbladder and stomach of the alligator (Alligator mississippiensis). Gen Comp Endocrinol 1997; 105: 91-101.
28. Schneider H, Sanger H, Hanisch E. In vitro effects of cholecystokinin fragments on human gallbladders. Evidence for an altered CCK-receptor structure in a subgroup of patients with gallstones. J Hepatol 1997; 26: 1063-8.
29. von Schrenck T, Moran TH, Heinz Erian P, Gardner JD, Jensen RT. Cholecystokinin receptors on gallbladder muscle and pancreatic acinar cells: a comparative study. Am J Physiol 1988; 255: G512-G521.
30. Aoki T, Ueno T, Toyonaga A, et al. Radiographic evidence of cholecystokinin octapeptide receptors in the hamster gallbladder. Scand J Gastroenterol 1991; 26: 1165-72.
31. 2+ mobilization by inositol-1,4,5-trisphosphate in isolated gastric smooth muscle cells. J Biol Chem 1986; 261: 16591-6.
32. Grider JR, Makhlouf GM. Regional and cellular heterogeneity of cholecystokinin receptors mediating muscle contraction in the gut. Gastroenterology 1987; 92: 175-80.
33. Severi C, Grider JR, Makhlouf GM. Functional gradients in muscle cells isolated from gallbladder, cystic duct, and common bile duct. Am J Physiol 1988; 255: G647-G652.
34. Severi C, Grider JR, Makhlouf GM. Identification of separate bombesin and substance P receptors on isolated muscle cells from canine gallbladder. J Pharmacol Exp Ther 1988; 245: 195-8.
35. Severi C, Grider JR, Makhlouf GM. Characterization of opioid receptors on isolated canine gallbladder smooth muscle cells. Life Sci 1988; 42: 2373-80.
36. Grider JR, Makhlouf GM. Distinct receptors for cholecystokinin and gastrin on muscle cells of stomach and gallbladder. Am J Physiol 1990; 259: G184-G190.
37. Morini G, Barocelli E, Impicciatore M, Grider JR, Makhlouf GM. Receptor type for cholecystokinin on isolated intestinal muscle cells of the guinea pig. Regul Peptides 1990; 28: 313-21.
38. Chen Q, Yu P, De Petris G, Biancani P, Behar J. Distinct muscarinic receptors and signal transduction pathways in gallbladder muscle. J Pharmacol Exp Ther 1995; 273: 650-5.
39. Yu P, Chen Q, Harnett KM, Amaral J, Biancani P, Behar J. Direct G protein activation reverses impaired CCK signaling in human gallbladders with cholesterol stones. Am J Physiol 1995; 269: G659-65.
40. Chen Q, De Petris G, Yu P, Amaral J, Biancani P, Behar J. Different pathways mediate cholecystokinin actions in cholelithiasis. Am J Physiol 1997; 272: G838-44.
41. Yu P, Chen Q, Biancani P, Behar J. Membrane cholesterol alters gallbladder muscle contractility in prairie dogs. Am J Physiol 1996; 271: G56-61.
42. Chen Q, Amaral J, Oh S, Biancani P, Behar J. Gallbladder relaxation in patients with pigment and cholesterol stones. Gastroenterology 1997; 113: 930-7.
43. Yu P, Chen Q, Harnett K, Biancani P, Behar J. Impaired IP3 and DAG production in human gallbladder muscle with cholesterol stones. Gastroenterology 1994; 107: A1220-30 (abstract).
44. Yu P, De Petris G, Biancani P, Amaral J, Behar J. Cholecystokinin-coupled intracellular signaling in human gallbladder muscle. Gastroenterology 1994; 106: 763-70.
45. Yu P, Harnett KM, Biancani P, De Petris G, Behar J. Interaction between signal transduction pathways contributing to gallbladder tonic contraction. Am J Physiol 1994; 265: 1082-9.
46. Yu P, Chen Q, Xiao Z, Harnett K, Biancani P, Behar J. Signal transduction pathways mediating CCK-induced gallbladder muscle contraction. Am J Physiol 1998; 275: G203-11.
47. Chen Q, Amaral J, Biancani P, Behar J. Excess membrane cholesterol alters human gallbladder muscle contractility and membrane fluidity. Gastroenterology 1999; 116: 678-85.
48. Behar J, Rhim BY, Thompson W, Biancani P. Inositol trisphosphate restores impaired human gallbladder motility associated with cholesterol stones. Gastroenterology 1993; 104: 563-8.
49. Portincasa P, Brandonisio R, Di Ciaula A, Maggi V, Chiloiro M, Palasciano G. The effect of a novel CCK-antagonist (lorglumide) on human and guinea pig gallbladder strips: a tensiometric study. Boll Soc Ital Biol Sper 1990; 66: 567-73.
50. Portincasa P, Di Ciaula A, Baldassarre G, et al. Gallbladder motor function in gallstone patients: sonographic and in vitro studies on the role of gallstones, smooth muscle function and gallbladder wall inflammation. J Hepatol 1994; 21: 430-40.
51. van de Heijning BJM, van de Meeberg P, Portincasa P, et al. Effects of ursodeoxycholic acid therapy on in vitro gallbladder contractility in patients with cholesterol gallstones. Dig Dis Sci 1999; 44: 190-6.
52. Fridhandler TM, Davison JS, Shaffer EA. Defective gallbladder contractility in the ground squirrel and prairie dog during the early stages of cholesterol gallstone formation. Gastroenterology 1983; 85: 830-6.
53. Pomeranz IS, Davison JS, Shaffer EA. The effects of prosthetic gallstones on gallbladder function and bile composition. J Surg Res 1986; 41: 47-52.
54. Shaffer EA, Bomzon A, Lax H, Davison JS. The source of calcium for CCK-induced contraction of the guinea-pig gallbladder. Regul Peptides 1992; 37: 15-26.
55. Xu QW, Shaffer EA. Cisapride improves gallbladder contractility and bile lipid composition in an animal model of gallstone disease. Gastroenterology 1993; 105: 1184-91.
56. Li YF, Russel DH, Myers ST, Weisbrodt NW, Moody FG. Gallbladder contractility in aspirin- and cholesterol-fed prairie dog. Gastroenterology 1984; 106: 1662-7.
57. Pauletzki JG, Xu QW, Shaffer EA. Inhibition of gallbladder emptying decreases cholesterol saturation in bile in the Richardson ground squirrel. Hepatology 1995; 22: 325-31.
58. Xu QW, Shaffer EA. The potential site of impaired gallbladder contractility in an animal model of cholesterol gallstone disease. Gastroenterology 1996; 110: 251-7.
59. Xu QW, Freedman SM, Shaffer EA. Inhibitory effect of bile salts on gallbladder smooth muscle contractility in the guinea pig in vitro. Gastroenterology 1997; 112: 1699-706.
60. Behar J, Biancani P. Pharmacologic characterization of excitatory and inhibitory cholecystokinin receptors of the cat gallbladder and sphincter of Oddi. Gastroenterology 1987; 92: 764-70.
61. Behar J, Lee KY, Thompson WR, Biancani P. Gallbladder contraction in patients with pigment and cholesterol stones. Gastroenterology 1989; 97: 1479-84.
62. Lee KY, Biancani P, Behar J. Calcium sources utilized by cholecystokinin and acetylcholine in the cat gallbladder muscle. Am J Physiol 1989; 256: G785-G788.
63. Chen Q, Chitinavis V, Xiao Z, et al. Impaired G protein function in gallbladder muscle from progesterone-treated guinea pigs. Am J Physiol 1998; 274: G283-9.
64. Xiao ZL, Chen Q, Biancani P, Behar J. Mechanisms of gallbladder hypomotility in pregnant guinea pigs. Gastroenterology 1999; 116: 411-9.
65. Pomeranz IS, Davison JS, Shaffer EA. Direct determination of the contractility of the guinea pig gallbladder: a new in vivo model. Can J Physiol Pharmacol 1985; 63: 1038-42.
66. Xu QW, Scott RB, Tan DT, Shaffer EA. Effect of the prokinetic agent, erythromycin, in the Richardson ground squirrel model of cholesterol gallstone disease. Hepatology 1998; 28: 613-9.
67. McKirdy ML, McKirdy HC, Johnson CD. Non-adrenergic non-cholinergic inhibitory innervation shown by electrical field stimulation of isolated strips of human gall bladder muscle. Gut 1994; 35: 412-6.
68. Bird NC, Wegstapel H, Chess-Williams R, Johnson AG. In vitro contractility of stimulated and non-stimulated human gallbladder muscle. Neurogastroenterol Motil 1996; 8: 63-8.
69. Freeley TM, Clanachan AS, Scott GW. Contractility of human gallbladder muscle in vitro. Aliment Pharmacol Ther 1987; 1: 607-16.
70. Schulz M, Hanisch E, Guldutuna S. In vitro contractility of the musculature of human gallbladders with and without gallstones - relevance of the prostaglandin system for CCK regulated motoricity. Z Gastroenterol 1993; 31: 376-87.
71. McKirdy ML, Johnson CD, McKirdy HC. Inflammation impairs neurally mediated responses to electrical field stimulation in isolated strips of human gallbladder muscle. Dig Dis Sci 1994; 39: 2229-34.
72. Xu QW, Scott RB, Tan DTM, Shaffer EA. Erythromycin as a prokinetic agent in an animal model of cholesterol gallstone disease. Gastroenterology 1995; 108: A441 (abstract).
73. Xu QW, Scott RB, Tan DTM, Shaffer EA. Slow intestinal transit: a motor disorder contributing to cholesterol gallstone formation in the ground squirrel. Hepatology 1996; 23: 1664-72.
74. Xu QW, Mantle M, Pauletzki JG, Shaffer EA. Sustained gallbladder stasis promotes cholesterol gallstone formation in the ground squirrel. Hepatology 1997; 26: 831-6.
75. Mansour A, Dawoud I, Gad-El-Hak N. The potential site of disordered gallbladder contractility during the early stage of cholesterol gallstone formation. Hepatogastroenterology 1998; 45: 1404-9.
76. Li YF, Moody FG, Weisbrodt NW, Zalewsky CA, Coelho JCU, Senninger N. Decrease of contractility of prairie dog gallbladder muscle strips following cholesterol feeding. Surg Forum 1984; 35: 224-6.
77. Portincasa P, Di Ciaula A, Vendemiale G et al. Gallbladder motility and cholesterol crystallization in bile from patients with pigment and cholesterol gallstones. Eur J Clin Invest 2000 (in press).
78. Portincasa P, Mitra P, Maghsoudldoo M, Murphy GM, Dowling RH. An integrated study of gallbladder (GB) motor function in gallstone patients. Gut 1987; 28: 1395A (abstract).
79. DeCarvalho S. Atherosclerosis. I. A leiomyoproliferative disease of the arteries resulting from the breakdown of the endothelial barrier to potent blood growth factors. Angiology 1995; 36: 497-710.
80. Stolk MFJ, van de Heijning BJM, van Erpecum KJ, Verheem A, Akkermans LMA, vanBerge-Henegouwen GP. Effect of bile salts on in vitro gallbladder motility: preliminary study. Ital J Gastroenterol 1996; 28: 105-10.
81. Jazrawi RP, Pazzi P, Petroni ML, et al. Postprandial gallbladder motor function: refilling and turnover of bile in health and cholelithiasis. Gastroenterology 1995; 109: 582-91.
82. Sanabria JR, Upadhya A, Mullen B, Harvey PRC, Strasberg SM. Effect of deoxycholate on immunoglobulin G concentration in bile: studies in humans and pigs. Hepatology 1995; 21: 215-22.
83. Parkman HP, Vozzelli MA, Pagano AP, Cowan A. Pharmacological analysis of receptors for bombesin-related peptides on guinea pig gallbladder smooth muscle. Regul Pept 1994; 52: 173-80.
84. Koutsoviti-Papadopoulou M, Kounenis G, Batzias G, Elezoglou V. Effect of cisapride on the isolated guinea pig gall bladder and common bile duct. Gen Pharmacol 1997; 29: 863-7.